Cargando…
Hepatocyte Nuclear Factor (HNF)‐4α Induces Expression of Endothelial Fas Ligand (FasL) to Prevent Cancer Cell Transmigration: A Novel Defense Mechanism of Endothelium against Cancer Metastasis
Endothelial Fas ligand (FasL) contributes to the “immune privilege” of tissues such as testis and eye, in which apoptosis is induced in infiltrating Fas‐positive activated T cells and results in the inhibition of leukocyte extravasation. In this study, we examined the role of endothelial FasL in con...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927027/ https://www.ncbi.nlm.nih.gov/pubmed/12036449 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01288.x |
_version_ | 1783319013455036416 |
---|---|
author | Osanai, Makoto Chiba, Hideki Kojima, Takashi Fujibe, Masato Kuwahara, Kazuhide Kimura, Hiromichi Satoh, Masaaki Sawada, Norimasa |
author_facet | Osanai, Makoto Chiba, Hideki Kojima, Takashi Fujibe, Masato Kuwahara, Kazuhide Kimura, Hiromichi Satoh, Masaaki Sawada, Norimasa |
author_sort | Osanai, Makoto |
collection | PubMed |
description | Endothelial Fas ligand (FasL) contributes to the “immune privilege” of tissues such as testis and eye, in which apoptosis is induced in infiltrating Fas‐positive activated T cells and results in the inhibition of leukocyte extravasation. In this study, we examined the role of endothelial FasL in controlling cancer cell transmigration using rat lung endothelial (RLE) cell line bearing a doxycycline‐inducible hepatocyte nuclear factor (HNF)‐4α expression system. We showed that a detectable level of FasL was expressed in RLE cells and that this expression was markedly up‐regulated and well correlated to the degree of HNF–4α expression in a time‐dependent manner. When various cancer cells were overlaid on an RLE monolayer sheet, we examined the ability of endothelial FasL to induce massive apoptosis in Fas‐expressing cancer cells and found a causal link to inhibition of the transmigration. Finally, we showed that FasL was expressed in capillaries of the rat brain by immunohistochemical staining, suggesting that FasL serves its functions not only in vitro, but also in vivo. These results raise the possibility that HNF–4α is involved in regulating cancer cell transmigration by modulating the Fas‐FasL system. |
format | Online Article Text |
id | pubmed-5927027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59270272018-05-11 Hepatocyte Nuclear Factor (HNF)‐4α Induces Expression of Endothelial Fas Ligand (FasL) to Prevent Cancer Cell Transmigration: A Novel Defense Mechanism of Endothelium against Cancer Metastasis Osanai, Makoto Chiba, Hideki Kojima, Takashi Fujibe, Masato Kuwahara, Kazuhide Kimura, Hiromichi Satoh, Masaaki Sawada, Norimasa Jpn J Cancer Res Article Endothelial Fas ligand (FasL) contributes to the “immune privilege” of tissues such as testis and eye, in which apoptosis is induced in infiltrating Fas‐positive activated T cells and results in the inhibition of leukocyte extravasation. In this study, we examined the role of endothelial FasL in controlling cancer cell transmigration using rat lung endothelial (RLE) cell line bearing a doxycycline‐inducible hepatocyte nuclear factor (HNF)‐4α expression system. We showed that a detectable level of FasL was expressed in RLE cells and that this expression was markedly up‐regulated and well correlated to the degree of HNF–4α expression in a time‐dependent manner. When various cancer cells were overlaid on an RLE monolayer sheet, we examined the ability of endothelial FasL to induce massive apoptosis in Fas‐expressing cancer cells and found a causal link to inhibition of the transmigration. Finally, we showed that FasL was expressed in capillaries of the rat brain by immunohistochemical staining, suggesting that FasL serves its functions not only in vitro, but also in vivo. These results raise the possibility that HNF–4α is involved in regulating cancer cell transmigration by modulating the Fas‐FasL system. Blackwell Publishing Ltd 2002-05 /pmc/articles/PMC5927027/ /pubmed/12036449 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01288.x Text en |
spellingShingle | Article Osanai, Makoto Chiba, Hideki Kojima, Takashi Fujibe, Masato Kuwahara, Kazuhide Kimura, Hiromichi Satoh, Masaaki Sawada, Norimasa Hepatocyte Nuclear Factor (HNF)‐4α Induces Expression of Endothelial Fas Ligand (FasL) to Prevent Cancer Cell Transmigration: A Novel Defense Mechanism of Endothelium against Cancer Metastasis |
title | Hepatocyte Nuclear Factor (HNF)‐4α Induces Expression of Endothelial Fas Ligand (FasL) to Prevent Cancer Cell Transmigration: A Novel Defense Mechanism of Endothelium against Cancer Metastasis |
title_full | Hepatocyte Nuclear Factor (HNF)‐4α Induces Expression of Endothelial Fas Ligand (FasL) to Prevent Cancer Cell Transmigration: A Novel Defense Mechanism of Endothelium against Cancer Metastasis |
title_fullStr | Hepatocyte Nuclear Factor (HNF)‐4α Induces Expression of Endothelial Fas Ligand (FasL) to Prevent Cancer Cell Transmigration: A Novel Defense Mechanism of Endothelium against Cancer Metastasis |
title_full_unstemmed | Hepatocyte Nuclear Factor (HNF)‐4α Induces Expression of Endothelial Fas Ligand (FasL) to Prevent Cancer Cell Transmigration: A Novel Defense Mechanism of Endothelium against Cancer Metastasis |
title_short | Hepatocyte Nuclear Factor (HNF)‐4α Induces Expression of Endothelial Fas Ligand (FasL) to Prevent Cancer Cell Transmigration: A Novel Defense Mechanism of Endothelium against Cancer Metastasis |
title_sort | hepatocyte nuclear factor (hnf)‐4α induces expression of endothelial fas ligand (fasl) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927027/ https://www.ncbi.nlm.nih.gov/pubmed/12036449 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01288.x |
work_keys_str_mv | AT osanaimakoto hepatocytenuclearfactorhnf4ainducesexpressionofendothelialfasligandfasltopreventcancercelltransmigrationanoveldefensemechanismofendotheliumagainstcancermetastasis AT chibahideki hepatocytenuclearfactorhnf4ainducesexpressionofendothelialfasligandfasltopreventcancercelltransmigrationanoveldefensemechanismofendotheliumagainstcancermetastasis AT kojimatakashi hepatocytenuclearfactorhnf4ainducesexpressionofendothelialfasligandfasltopreventcancercelltransmigrationanoveldefensemechanismofendotheliumagainstcancermetastasis AT fujibemasato hepatocytenuclearfactorhnf4ainducesexpressionofendothelialfasligandfasltopreventcancercelltransmigrationanoveldefensemechanismofendotheliumagainstcancermetastasis AT kuwaharakazuhide hepatocytenuclearfactorhnf4ainducesexpressionofendothelialfasligandfasltopreventcancercelltransmigrationanoveldefensemechanismofendotheliumagainstcancermetastasis AT kimurahiromichi hepatocytenuclearfactorhnf4ainducesexpressionofendothelialfasligandfasltopreventcancercelltransmigrationanoveldefensemechanismofendotheliumagainstcancermetastasis AT satohmasaaki hepatocytenuclearfactorhnf4ainducesexpressionofendothelialfasligandfasltopreventcancercelltransmigrationanoveldefensemechanismofendotheliumagainstcancermetastasis AT sawadanorimasa hepatocytenuclearfactorhnf4ainducesexpressionofendothelialfasligandfasltopreventcancercelltransmigrationanoveldefensemechanismofendotheliumagainstcancermetastasis |